Rowlands - a non-executive since 2014 - bought 114,000 shares at
After the transaction, Rowlands held 328,516 shares in Spire.
Wed, 21st Mar 2018 13:21
Rowlands - a non-executive since 2014 - bought 114,000 shares at
After the transaction, Rowlands held 328,516 shares in Spire.
UK EXECUTIVE CHANGE SUMMARY: Cheshire Steps Down As Barclays UK Chair
Read more(Sharecast News) - National Grid: Citigroup upgrades to buy with a target price of 970p.
Read moreUK BROKER RATINGS SUMMARY: Citi Upgrades National Grid And 3i Group
Read moreIN BRIEF: Spire Healthcare In Talks With NHS England For New Contract
Read moreSpire Healthcare Writes To 5,500 Ex-Patients Of Disgraced Surgeon
Read moreUK BROKER RATINGS SUMMARY: BofA Raises Lloyds; Liberum Likes Landsec
Read moreLONDON BRIEFING: Blue Wave Hits Red Wall In Tight US Presidential Vote
Read more(Sharecast News) - DCC: RBC Capital Markets upgrades to outperform with a target price of 7,400p.
Read moreUK BROKER RATINGS SUMMARY: RBC Raises DCC; Credit Suisse Cuts Aveva
Read more(Sharecast News) - Take a deep breath. It's possible to do good and make money - at the same time even.
Read more(Sharecast News) - William Hill: RBC Capital Markets downgrades to sector perform with a target price of 300.0p.
Read more(Sharecast News) - JPMorgan Cazenove upgraded private hospital operator Spire Healthcare to 'overweight' from 'neutral' and lifted the price target to 175p from 136p as it said pent-up demand is building in both the private sector and the NHS and that Spire is well-placed to deliver capacity.
Read moreUK BROKER RATINGS SUMMARY: ODDO BHF Upgrades Astra And Glaxo
Read moreSpire Healthcare Withholds Dividend Amid Swing To First Half Loss
Read more(Sharecast News) - Spire Healthcare swung to a first-half loss as the company wrote down £200m of goodwill and reported a pickup in demand for operations.
Read more